Orion completes acquisition of LegoChem Biosciences

Reporter Kim SangJin / approved : 2024-04-01 03:57:19
  • -
  • +
  • 인쇄

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

Alphabiz Reporter Kim SangJin(hoondork1977@alphabiz.co.kr)

어플

주요기사

Financial Supervisory Service to Launch On-Site Inspection of BNK Financial Group Next Month2025.12.22
LG Electronics Partners with Japan’s Top F&B POS Provider Yusen to Roll Out Digital Kiosks Nationwide2025.12.22
Kakao Faces Backlash Over Expanded User Data Collection Starting February 20262025.12.22
Kakao in Talks to Sell Portal “Daum” to AI Startup Upstage2025.12.22
Hanwha Aerospace to Export Korean ‘Cheonmu’ Multiple Rocket Launcher to Estonia2025.12.22
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사